Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Starling Oncology, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 3.90M | 4.15M | +249.5K (+6.4%) |
| Value | $172.4K | $163.5K | −$8.88K (−5.2%) |
New holders (1)
Institutions that held Starling Oncology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 17,115 | $702 | 0.00% |
Sold out (0)
Institutions that held Starling Oncology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.